Literature DB >> 25434764

A qualitative study exploring male cancer patients' experiences with percutaneous nephrostomy.

Lene Hyldgaard Bigum1, Marlène Elisabeth Spielmann, Gitte Juhl, Annlise Rasmussen.   

Abstract

OBJECTIVE: Obstructive uropathy due to advanced cancer can be efficiently treated with a percutaneous nephrostomy. The treatment is associated with complications and frequent readmissions. How the patients' quality of life is affected by a nephrostomy remains uncertain. The aim of this study was to describe how a nephrostomy is perceived by patients and its effects on their everyday lives.
MATERIAL AND METHODS: Semi-structured interviews were conducted in the patients' home using a mind map. The inclusion criteria were locally advanced or metastatic urological cancer treated with a nephrostomy for a minimum of 1 month. All interviews were audio recorded, transcribed and analysed using a grounded theory approach. Ten male patients were interviewed, eight with prostate cancer and two with bladder cancer.
RESULTS: Treatment with nephrostomy influenced the physical activity level and restricted normal social activities. Readmissions had a negative influence on mood. However, the patients who experienced symptom improvement were thankful for having had the nephrostomy, despite the inconveniences. Communicating about the hazards and benefits helped patients to adjust their expectations of a nephrostomy.
CONCLUSIONS: The study describes how nephrostomy is a burdensome intervention accompanied by a plethora of complex physical and psychosocial issues. Having a nephrostomy on a palliative indication has extensive implications for the patients, which should not be neglected or underestimated. Individual assessment of each patient, together with excellent communication regarding the procedure and outcome, is essential. Most patients had frequent contact with the healthcare system and additional support could be offered by a palliative care service.

Entities:  

Keywords:  cancer; hydronephrosis; malignant ureter obstruction; nephrostomy; qualitative research; urinary diversion

Mesh:

Year:  2014        PMID: 25434764     DOI: 10.3109/21681805.2014.938694

Source DB:  PubMed          Journal:  Scand J Urol        ISSN: 2168-1805            Impact factor:   1.612


  7 in total

1.  Using a three-dimensional computer assisted stone volume estimates to evaluate extracorporeal shockwave lithotripsy treatment of kidney stones.

Authors:  Lene Hyldgaard Bigum; Peter Sommer Ulriksen; Omar Salah Omar
Journal:  Urolithiasis       Date:  2016-02-25       Impact factor: 3.436

Review 2.  Malignant ureteric obstruction decompression: how much gain for how much pain? A narrative review.

Authors:  Joanna Prentice; Tarik Amer; Ali Tasleem; Omar Aboumarzouk
Journal:  J R Soc Med       Date:  2018-04       Impact factor: 5.344

3.  [Comparison of catheter-associated quality of life in external urinary diversion: nephrostomy vs. suprapubic catheter].

Authors:  A Wiedemann; M Weinhofer; J Stein; C Linné; R Kirschner-Hermanns; A Schorn; A Wagner; V Moll; U Unger; J Salem; T Liebald; A Bannowsky; S Wirz; E Brammen; H-J Heppner
Journal:  Urologe A       Date:  2022-01-13       Impact factor: 0.639

4.  A case of CRPC with multiple bladder invasions treated with EBRT followed by HDR-BT boost.

Authors:  Yoshiaki Takagawa; Jun Itami
Journal:  BJR Case Rep       Date:  2022-03-09

Review 5.  Practical aspects of palliative care & palliative radiotherapy in incurable cervical cancer.

Authors:  Reena George; Bhavana Rai
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

Review 6.  Outcomes Related to Percutaneous Nephrostomies (PCN) in Malignancy-Associated Ureteric Obstruction: A Systematic Review of the Literature.

Authors:  Francesca J New; Sally J Deverill; Bhaskar K Somani
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

Review 7.  Role of percutaneous nephrostomy in end of life prostate cancer patients: a systematic review of the literature.

Authors:  Francesca New; Sally Deverill; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2018-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.